- Home
- WAFU vs XBIO Comparison
WAFU vs XBIO Comparison
Compare WAFU & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- XBIO
- Stock Information
- Founded
- WAFU 1999
- XBIO N/A
- Country
- WAFU China
- XBIO United States
- Employees
- WAFU N/A
- XBIO N/A
- Industry
- WAFU Other Consumer Services
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- WAFU Real Estate
- XBIO Health Care
- Exchange
- WAFU Nasdaq
- XBIO Nasdaq
- Market Cap
- WAFU 7.1M
- XBIO 6.3M
- IPO Year
- WAFU 2019
- XBIO N/A
- Fundamental
- Price
- WAFU $1.47
- XBIO $4.06
- Analyst Decision
- WAFU
- XBIO Hold
- Analyst Count
- WAFU 0
- XBIO 1
- Target Price
- WAFU N/A
- XBIO N/A
- AVG Volume (30 Days)
- WAFU 21.8K
- XBIO 22.9K
- Earning Date
- WAFU 01-01-0001
- XBIO 11-12-2024
- Dividend Yield
- WAFU N/A
- XBIO N/A
- EPS Growth
- WAFU N/A
- XBIO N/A
- EPS
- WAFU N/A
- XBIO N/A
- Revenue
- WAFU $7,223,220.00
- XBIO $2,523,427.00
- Revenue This Year
- WAFU N/A
- XBIO N/A
- Revenue Next Year
- WAFU N/A
- XBIO N/A
- P/E Ratio
- WAFU N/A
- XBIO N/A
- Revenue Growth
- WAFU N/A
- XBIO 7.15
- 52 Week Low
- WAFU $1.46
- XBIO $2.78
- 52 Week High
- WAFU $2.85
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- WAFU 33.27
- XBIO 47.20
- Support Level
- WAFU $1.46
- XBIO $3.92
- Resistance Level
- WAFU $1.59
- XBIO $4.27
- Average True Range (ATR)
- WAFU 0.10
- XBIO 0.27
- MACD
- WAFU -0.01
- XBIO -0.05
- Stochastic Oscillator
- WAFU 2.86
- XBIO 19.09
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.